Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal.

G C Harris1, G Aston-Jones

  • 1University of Pennsylvania, VAMC 151 Rm A520, University and Woodland Ave, Philadephia, PA 19104, USA.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|December 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Locus coeruleus: From global projection system to adaptive regulation of behavior.

Brain research·2016
Same author

Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons.

Neuropharmacology·2012
Same author

Systems genetics approach reveals candidate genes for parasite resistance from quantitative trait loci studies in agricultural species.

Animal genetics·2012
Same author

Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats.

Proceedings of the National Academy of Sciences of the United States of America·2008
Same author

Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function.

Neuroscience·2007
Same author

Glutamate-associated plasticity in the ventral tegmental area is necessary for conditioning environmental stimuli with morphine.

Neuroscience·2004

Boosting serotonin levels with drugs like fluoxetine can reduce morphine cravings in withdrawn rats. This suggests serotonin augmentation may help combat opioid dependence.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Acute morphine increases serotonin (5-HT) in brain reward areas.
  • Chronic morphine withdrawal decreases 5-HT transmission.
  • Morphine withdrawal is associated with heightened anxiety and drug-seeking behavior.

Purpose of the Study:

  • To investigate the role of serotonin in morphine dependence and withdrawal.
  • To determine if augmenting serotonin levels can reduce morphine preference and anxiety during withdrawal.

Main Methods:

  • Administered fluoxetine or 5-hydroxytryptophan (5-HTP) to morphine-withdrawn rats.
  • Microinjected fluoxetine into the nucleus accumbens.
  • Assessed conditioned place preference for morphine-associated environments.

Related Experiment Videos

  • Measured anxiety levels in withdrawn rats.

    • Main Results:

    • Serotonin-boosting agents (fluoxetine, 5-HTP) abolished morphine-associated environment preference in withdrawn rats.
    • Nucleus accumbens fluoxetine administration yielded similar results.
    • Acute morphine preference was enhanced by these agents.
    • Fluoxetine reduced anxiety in morphine-withdrawn rats.

    Conclusions:

    • Augmenting brain serotonin levels can reduce the motivation to seek morphine during withdrawal.
    • Serotonin-modulating drugs show potential for treating opioid use disorder.